AI
SOLV icon

Accredited Investors’s Solventum SOLV Stock Holding History

Accredited Investors’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$661K Buy
8,563
+203
+2% +$14.8K 0.03% 152
2026
Q1 		$546K Sell
8,360
-15
-0.2% -$1.11K 0.03% 151
2025
Q4 		$664K Buy
8,375
+15
+0.2% +$1.15K 0.04% 138
2025
Q3 		$610K Sell
8,360
-255
-3% -$18.7K 0.03% 132
2025
Q2 		$653K Hold
8,615
– – 0.04% 123
2025
Q1 		$655K Hold
8,615
– – 0.04% 112
2024
Q4 		$569K Sell
8,615
-108
-1% -$7.56K 0.03% 121
2024
Q3 		$608K Buy
8,723
+1,079
+14% +$64.9K 0.03% 119
2024
Q2 		$404K Buy
+7,644
New +$464K 0.03% 139

Other funds holding SOLV

IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TFM
Trian Fund Management New York $4.23B AUM 31.93% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Accredited Investors's SOLV Position: Q2 2026 in Review

Accredited Investors increased its Solventum (SOLV) stake by 2.4% in Q2 2026, buying an estimated $14.8K and bringing the position to 8,563 shares worth $661K. The position accounts for 0.03% of the portfolio, ranked #152.

Accredited Investors first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $664K in Q4 2025. 882 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Accredited Investors held 8,563 shares of Solventum worth $661K as of Q2 2026.
  • Accredited Investors bought 203 Solventum shares in Q2 2026, an estimated $14.8K.
  • Solventum made up 0.03% of Accredited Investors's portfolio in Q2 2026, its #152 holding.
  • Accredited Investors first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Accredited Investors's Solventum position peaked at $664K in Q4 2025.
  • 882 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Accredited Investors's 13F filing for Q2 2026, filed 21 Jul 2026.